| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 30-Mar-26 | Placing | Tuomo Pätsi | 43.46p | 400,002 | £173,840.90 |
| 24-Mar-26 | Placing | Markku Jalkanen | 43.27p | 100,008 | £43,275.45 |
| 17-Mar-26 | Placing | Juho Jalkanen | 0.50 | 684 | 308.11 |
| 17-Mar-26 | Placing | Juho Jalkanen | 0.50 | 684 | 308.11 |
| 17-Mar-26 | Placing | Juho Jalkanen | 0.50 | 1,431 | 644.59 |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 30-Mar-26 | Placing | Tuomo Pätsi | 43.46p | 400,002 | £173,840.90 |
| 24-Mar-26 | Placing | Markku Jalkanen | 43.27p | 100,008 | £43,275.45 |
| 17-Sep-25 | Exercise of option | Juho Jalkanen | 94.50p | 30,000 | £28,348.51 |
| 17-Sep-25 | Buy | Yrjö E K Wichmann | 94.50p | 30,000 | £28,348.51 |
| 17-Mar-26 | Placing | Juho Jalkanen | 0.50 | 23,796 | 10,718.92 |
| Notifier | Holding | Value* |
|---|---|---|
| Markku Jalkanen | 1,725,274 | £667,681 |
| Tuomo Pätsi | 453,267 | £175,414 |
| John Poulos | 10,000 | £3,870 |
| Juho Jalkanen | 1,368 | £529 |
| Notifier** | Holding | Value* |
|---|---|---|
| Canaccord Genuity Group Inc | 49,596,067 | £19,193,678 |
| Heights Capital Management, Inc. | 47,211,351 | £18,270,793 |
| Faron Pharmaceuticals Ltd | 21,342,679 | £8,259,617 |
| Timo Syrjälä | 14,712,470 | £5,693,726 |
| Tom-Erik Lind | 14,697,112 | £5,687,782 |
| Blood Cancer United Inc | 7,037,426 | £2,723,484 |
| The European Investment Council Fund, EIC | 3,630,437 | £1,404,979 |
| A&B (HK) Company Limited | 3,559,893 | £1,377,679 |
| Markku Jalkanen (incl. Sirpa Jalkanen) | 3,413,434 | £1,320,999 |
| Marko Salmi | 2,667,707 | £1,032,403 |
| The Fourth Swedish National Pension Fund | 2,632,385 | £1,018,733 |
| Aviva Investors Global Services Limited | 2,271,669 | £879,136 |
| Canaccord Genuity Group Inc | 1,475,875 | £571,164 |
| Polar Capital LLP | 1,452,381 | £562,071 |
| Legal & General Investment Management Limited | 1,365,000 | £528,255 |
| Aviva plc & its subsidiaries | 1,287,262 | £498,170 |
| Juho Jalkanen | 1,142,015 | £441,960 |
| Currency | UK Pounds |
| Share Price | 38.70p |
| Change Today | -1.30p |
| % Change | -3.25 % |
| 52 Week High | 238.92 |
| 52 Week Low | 38.70 |
| Volume | 134,009 |
| Shares Issued | 224.35m |
| Market Cap | £86.82m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 1 |
| Buy | 3 |
| Neutral | 0 |
| Sell | 1 |
| Strong Sell | 1 |
| Total | 6 |

| No dividends found |
| Time | Volume / Share Price |
| 16:20 | 70,000 @ 39.00p |
| 16:36 | 103 @ 38.70p |
| 16:35 | 130 @ 38.70p |
| 16:35 | 103 @ 38.70p |
| 16:35 | 27 @ 38.70p |
| CEO | Juho Jalkanen |
| Chair | Tuomo Pätsi |
| CFO | Jurriaan Dekkers |
You are here: research